High-Dose Therapy (Hdt) With Autologous Hematopoietic Stem Cell Transplantation (Hsct) In Patients With Poor Prognosis Ewing Family Tumors (Eft).

E. Bolotin, Marianna Shakhnovits,Laurence J.N. Cooper,Dajun Qian,D. Hitt,Robert Sweetman,Judith K. Sato,James S. Miser,Stephen J. Forman,Joseph Rosenthal

BLOOD（2005）

引用 0|浏览14

暂无评分

摘要

Purpose: To evaluate the feasibility and safety of treatment with two cycles of HDT followed by autologous HSCT in patients (pts.) with poor prognosis EFT.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要